Royal Philips Electronics (NYSE: PHG, AEX: PHIA) announced that CX50 xMATRIX, the world's first portable ultrasound with Philips' industry leading Live 3D TEE, now offers 2-D Intracardiac Echo (ICE) capability. The CX50 xMATRIX with available Live 3D TEE and ICE is shown in Paris at the EuroPCR, official meeting for the European Association of Percutaneous Cardiovascular Inventions (EAPCI), May 21-24.
Cumbria Partnership NHS Foundation Trust has selected FairWarning® Patient Privacy Monitoring solution. This is part of the trust's strategy to become a leader in meeting the government's target for a 'paperless NHS' by 2018. It will also help to emphasise its reputation as a trusted provider of care.
Birmingham City Council has celebrated the first anniversary of their joint city-wide telecare service, which has to date benefitted 7,000 people across the city. The Birmingham Telecare Service, which aims to support 27,000 people by 2015, enables residents with a wide range of support-needs to remain living independently in their own homes.
IMS MAXIMS, a leading provider of clinical information systems, is implementing software into NHS trusts that will ensure risk assessments take place that will help to significantly reduce the number of preventable deaths caused by VTE in UK hospitals every year.
Royal Philips (NYSE: PHG, AEX: PHIA), the Radboud University Nijmegen Medical Centre (Nijmegen, the Netherlands) and Main-Taunus Cardiac Center (Bad Soden, Germany) today announced the results of a clinical study that demonstrate that the safety for patients and clinicians can be significantly enhanced during cardiac interventions.